Urine pp 147-153 | Cite as

Application of Urine Proteome in Cardiac Diseases Biomarker Discovery

  • Mindi Zhao


The cardiac disease is a common disorder and is considered as one of the leading causes of death around the world. The early detection of cardiac diseases is urgently needed. Though some diagnostic biomarkers have been used in prediction of diverse cardiac diseases in clinical practice, they are not enough good as expected. The urine proteome studies of cardiac diseases were relatively less than the plasma studies; however, they may provide some useful clues for prediction of the cardiac diseases with the development of high-resolution mass spectrometry technology. In this chapter, we summarize the urinary diagnostic protein biomarker of cardiac diseases (animal models and patients) and review recent urine proteome studies of coronary artery disease, myocarditis, and heart failure. These findings may provide clues for the pathogenesis of diseases, and the results may show that urine is a good source of cardiac diseases biomarkers.


Urine proteome Cardiac disease Biomarker 


  1. An M, Gao Y. Urinary biomarkers of brain diseases. Genomics Proteomics Bioinformatics. 2015;13:345–54.CrossRefGoogle Scholar
  2. Arzamendi D, Benito B, Tizon-Marcos H, Flores J, et al. Increase in sudden death from coronary artery disease in young adults. Am Heart J. 2011;161:574–80.CrossRefGoogle Scholar
  3. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, et al. Heart disease and stroke Statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–603.CrossRefGoogle Scholar
  4. D’Ambrosio A, Patti G, Manzoli A, Sinagra G, et al. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart. 2001;85:499–504.CrossRefGoogle Scholar
  5. Fihn SD, Gardin JM, Abrams J, Berra K et al (2012) ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 126:e354–e471.Google Scholar
  6. Fox K, Garcia MA, Ardissino D, Buszman P, et al. Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European Society of Cardiology. Eur Heart J. 2006;27:1341–81.CrossRefGoogle Scholar
  7. Han ZJ, Wu XD, Cheng JJ, Zhao SD, et al. Diagnostic accuracy of natriuretic peptides for heart failure in patients with pleural effusion: a systematic review and updated meta-analysis. PLoS One. 2015;10:e0134376.CrossRefGoogle Scholar
  8. Hou LN, Li F, Zeng QC, Su L, et al. Excretion of urinary orosomucoid 1 protein is elevated in patients with chronic heart failure. PLoS One. 2014;9:e107550.CrossRefGoogle Scholar
  9. Htun NM, Magliano DJ, Zhang ZY, Lyons J, et al. Prediction of acute coronary syndromes by urinary proteome analysis. PLoS One. 2017;12:e0172036.CrossRefGoogle Scholar
  10. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, et al. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010;121:948–54.CrossRefGoogle Scholar
  11. Mokou M, Lygirou V, Vlahou A, Mischak H. Proteomics in cardiovascular disease: recent progress and clinical implication and implementation. Expert Rev Proteomics. 2017;14:117–36.CrossRefGoogle Scholar
  12. Mullen W, Gonzalez J, Siwy J, Franke J, et al. A pilot study on the effect of short-term consumption of a polyphenol rich drink on biomarkers of coronary artery disease defined by urinary proteomics. J Agric Food Chem. 2011;59:12850–7.CrossRefGoogle Scholar
  13. Neisius U, Koeck T, Mischak H, Rossi SH, et al. Urine proteomics in the diagnosis of stable angina. BMC Cardiovasc Disord. 2016;16:70.CrossRefGoogle Scholar
  14. Rose NR, Herskowitz A, Neumann DA. Autoimmunity in myocarditis: models and mechanisms. Clin Immunol Immunopathol. 1993;68:95–9.CrossRefGoogle Scholar
  15. Rossing K, Bosselmann HS, Gustafsson F, Zhang ZY, et al. Urinary proteomics pilot study for biomarker discovery and diagnosis in heart failure with reduced ejection fraction. PLoS One. 2016;11:e0157167.CrossRefGoogle Scholar
  16. Rothlisberger S, Pedroza-Diaz J. Urine protein biomarkers for detection of cardiovascular disease and their use for the clinic. Expert Rev Proteomics. 2017;14:1091–103.CrossRefGoogle Scholar
  17. Sagar S, Liu PP, Cooper LT Jr. Myocarditis. Lancet. 2012;379:738–47.CrossRefGoogle Scholar
  18. Shao C, Li M, Li X, Wei L, et al. A tool for biomarker discovery in the urinary proteome: a manually curated human and animal urine protein biomarker database. Mol Cell Proteomics. 2011;10:M111 010975.CrossRefGoogle Scholar
  19. von Zur Muhlen C, Schiffer E, Zuerbig P, Kellmann M, et al. Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients. J Proteome Res. 2009;8:335–45.CrossRefGoogle Scholar
  20. Wu J, Gao Y. Physiological conditions can be reflected in human urine proteome and metabolome. Expert Rev Proteomics. 2015;12:623–36.CrossRefGoogle Scholar
  21. Zhang ZY, Ravassa S, Nkuipou-Kenfack E, Yang WY, et al. Novel urinary Peptidomic classifier predicts incident heart failure. J Am Heart Assoc. 2017;6:e005432.PubMedPubMedCentralGoogle Scholar
  22. Zhao M, Wu J, Li X, Gao Y. Urinary candidate biomarkers in an experimental autoimmune myocarditis rat model. J Proteome. 2018;179:71–9.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Mindi Zhao
    • 1
  1. 1.Department of Laboratory MedicineBeijing Hospital, National Center of GerontologyBeijingChina

Personalised recommendations